Global Point-of-care Diagnostics Market Growth, Trends & Forecasts (2017 - 2022)

The global market for Point-of-care diagnostics is poised to reach $XX million by the end of 2020 growing at a CAGR of XX%. Point-of-care testing allows patient diagnoses in the physicians office, an ambulance, the home, the field, or in the hospital. The results of care are timely, and allow rapid treatment to the patient. Empowering clinicians to make decisions at the point-of-care has the potential to significantly impact health care delivery and to address the challenges of health disparities. The success of a potential shift from curative medicine, to predictive, personalized, and preemptive medicine could rely on the development of portable diagnostic and monitoring devices for point-of-care testing.

Currently, North America is the largest market for point of care diagnostics followed by the likes of Europe. APAC is the fastest growing segment. The global point of care diagnostics market can be segmented on the basis of Product (Infectious diseases, glucose monitoring, cardiac markers, hematology, oncology markers, coagulation, OTC diagnostics tests, urinalysis, fertility testing and others), End users (Hospitals, laboratories, home healthcare and others), Mode of delivery (Prescription, OTC), Geography (North America, Europe, APAC & RoW).


Increase in the number of chronic diseases, rapid rise in the aging population, technological advances, increased awareness among the population, increased R&D spend to develop novel products, low penetration of POC diagnostics in the emerging economies and rapid economic development in the emerging nations are the major driving factors for the growth of the market.


Reluctance from the industry towards changing the existing norms, product recalls, stringent regulatory framework and unfavorable reimbursement scenario are the challenges faced by the POC diagnostics market.

What the report offers

Market Definition for the specified topic along with identification of key drivers and restraints for the market.
Market analysis for the Global Point-of-Care Diagnostics Market, with region specific assessments and competition analysis on a global and regional scale.
Identification of factors instrumental in changing the market scenarios, rising prospective opportunities and identification of key companies which can influence the market on a global and regional scale.
Extensively researched competitive landscape section with profiles of major companies along with their strategic initiatives and market shares.
Identification and analysis of the Macro and Micro factors that affect the Global Point-of-Care Diagnostics market on both global and regional scale.
A comprehensive list of key market players along with the analysis of their current strategic interests and key financial information.

1. Introduction

1.1 Report Description

1.2 Research Methodology

2. Key Findings

3. Executive Summary

4. Market Dynamics

4.1 Market Segmentation

4.2 Market Drivers

4.2.1 Increase in the number of chronic & infectious diseases

4.2.2 Rapid aging population

4.2.3 Technological advances

4.2.4 General awareness about healthcare among the population

4.2.5 Increase in the adoption of Home based healthcare technologies

4.2.6 Increase in the investments on R&D to develop novel products

4.2.7 Low penetration of POC diagnostics in the emerging economies

4.2.8 Rapid economic development in the emerging nations

4.3 Market Restraints

4.3.1 Reluctance from the medical indsutry towards changing the existing norms

4.3.2 Product recalls

4.3.3 Lack of co-ordination among healthcare organizations

4.3.4 Stringent regulatory framework

4.3.5 Unfavorable reimbursement scenario

5. Global Market Segmentation

5.1 By Product

5.1.1 Infectious Diseases

5.1.2 Glucose Monitoring

5.1.3 Cardiac Markers

5.1.4 Hematology

5.1.5 Oncology Markers

5.1.6 Coagulation

5.1.7 OTC Diagnostic Tests

5.1.8 Urinalysis

5.1.9 Drugs of abuse

5.1.10 Fertility Testing

5.1.11 Blood Gas Testing

5.1.12 Others

5.2 By End Users

5.2.1 Hospitals

5.2.2 Laboratories

5.2.3 Home Healthcare

5.2.4 Others

5.3 By Mode of Delivery

5.3.1 OTC

5.3.2 Prescription

5.4 By Geography

5.4.1 North America US Canada Mexico

5.4.2 Europe UK Germany France Spain Italy Rest of Europe

5.4.3 Asia Pacific China Japan India South Korea Rest of Asia Pacific

5.4.4 Rest of the World

6. Competitive Landscape

6.1 Mergers & Acquisitions

6.2 Agreements, Collaborations & Partnerships

6.3 New Product Launches

6.4 Recommendations to new market players

7. Company Profiles

7.1 Abbott Laboratories

7.2 Agendia

7.3 Agilent/Dako

7.4 Alere Inc

7.5 Arkray Inc

7.6 Bayer AG

7.7 Becton Dickinson & Company

7.8 Biomerieux

7.9 BioRad Laboratories

7.10 Cepheid

7.11 Danaher Corporation

7.12 Foundation Medicine

7.13 Genomic Health

7.14 Grifols

7.15 Hologic

7.16 Illumina

7.17 Johnson & Johnsons

7.18 Myriad Genetics

7.19 QIagen

7.20 Roche Diagnostics

7.21 Siemens

7.22 Sysmex

8. Appendix

8.1 Abbreviations

8.2 Sources

8.3 Bibliography

8.4 Disclaimer

Content are not available

Choose License Type